| (₹ crores) | Q2FY26 | Q1FY26 | Q2FY25 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 87.90 | 62.98 | 78.69 | 39.6% | 11.7% |
Total Expenses | 77.62 | 69.98 | 73.62 | 10.9% | 5.4% |
Profit Before Tax | 10.28 | -7.00 | 5.07 | -246.9% | 102.8% |
Tax | 2.37 | -1.49 | 0.92 | -259.1% | 157.6% |
Profit After Tax | 7.91 | -5.51 | 4.15 | -243.6% | 90.6% |
Earnings Per Share | 1.42 | -1.00 | 0.75 | -242.0% | 89.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Quick Heal Technologies Ltd is a prominent cybersecurity firm specializing in providing a wide range of products and services designed to enhance digital security. The company is well-known for its antivirus software solutions, catering to both individual consumers and enterprises. These solutions include desktop and mobile security applications, cloud-based security, and endpoint protection systems. Quick Heal operates within the technology and cybersecurity industry, which is characterized by rapid advancements and a high demand for innovative security solutions. Key developments in the industry often revolve around addressing new and evolving cyber threats. As of the latest available information, there are no major recent developments specific to Quick Heal Technologies Ltd beyond its ongoing product and service offerings.
Quick Heal Technologies Ltd reported a total income of ₹87.90 crores in Q2FY26, showing a substantial quarter-over-quarter (QoQ) increase of 39.6% compared to ₹62.98 crores in Q1FY26. Year-over-year (YoY), the total income increased by 11.7% from ₹78.69 crores in Q2FY25. This data reflects a robust improvement in revenue generation for the quarter under review. The rise in revenue could be attributed to enhanced sales performance, possibly driven by increased demand for cybersecurity solutions. However, specific factors contributing to this increase are not detailed in the available data.
In terms of profitability, Quick Heal Technologies Ltd demonstrated a significant turnaround with a profit before tax (PBT) of ₹10.28 crores in Q2FY26. This marks a dramatic improvement from a loss of ₹7.00 crores in Q1FY26, representing a QoQ change of -246.9%. The profit before tax also increased by 102.8% YoY compared to ₹5.07 crores in Q2FY25. The tax expense for Q2FY26 was ₹2.37 crores, which is a reversal from a tax credit of ₹1.49 crores in Q1FY26, showing a QoQ change of -259.1%. Year-over-year, the tax increased by 157.6% from ₹0.92 crores in Q2FY25. Consequently, the profit after tax (PAT) for Q2FY26 was ₹7.91 crores, compared to a loss of ₹5.51 crores in the previous quarter, resulting in a QoQ change of -243.6%. The PAT showed a YoY increase of 90.6% from ₹4.15 crores in Q2FY25. Earnings per share (EPS) followed a similar pattern, with Q2FY26 showing ₹1.42 compared to a negative ₹1.00 in Q1FY26, and a YoY increase of 89.3% from ₹0.75 in Q2FY25.
Operating metrics for Quick Heal Technologies Ltd are reflected in the total expenses, which amounted to ₹77.62 crores in Q2FY26. This represents a 10.9% increase QoQ from ₹69.98 crores in Q1FY26 and a 5.4% increase YoY from ₹73.62 crores in Q2FY25. The increase in expenses may relate to higher operational costs or investments in growth initiatives, although specifics are not provided in the data. The cost structure and efficiency improvements are critical aspects that contribute to the overall financial performance observed in the profit indicators.
Quick Heal Technologies Ltd announced its Q2 FY 2025-26 results on 26 October, 2025.
Quick Heal Technologies Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Quick Heal Technologies Ltd Q2 FY 2025-26 results include:
Quick Heal Technologies Ltd reported a net loss of ₹7.91 crore in Q2 FY 2025-26, reflecting a 90.6% year-over-year growth.
Quick Heal Technologies Ltd posted a revenue of ₹87.90 crore in Q2 FY 2025-26.